Parkinson's Disease Clinical Trials in Michigan

22 recruiting studies across 3 cities

All Trials in Michigan

Phase
Trial Phase Location
A Pilot Study of In-lab Dynamic Standing in Parkinson's DiseasePhase 1Ann Arbor
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsPhase 2Ann Arbor
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 3Ann Arbor
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—Ann Arbor
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's DiseasePhase 2Ann Arbor
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—Ann Arbor
Parkinson's Foundation PD GENEration Genetic Registry—Ann Arbor
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive ImpairmentsPhase 1/2Ann Arbor
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 4Ann Arbor
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation—Ann Arbor
Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven EnhancementsN/AEast Lansing
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's DiseasePhase 1Farmington Hills
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2Farmington Hills
A Study of Buntanetap in Participants With PDPhase 2/3Farmington Hills
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 4Farmington Hills
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseasePhase 1Farmington Hills
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/3Farmington Hills
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3Farmington Hills
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic TherapyPhase 2Farmington Hills
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor FluctuationsPhase 2Farmington Hills
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease—Farmington Hills
SAD Study in Patients With Parkinson's Disease and Motor FluctuationsPhase 1Farmington Hills

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.